Pregabalin in Treatment of Postdural Puncture Headache

PHASE3CompletedINTERVENTIONAL
Enrollment

75

Participants

Timeline

Start Date

February 28, 2024

Primary Completion Date

August 15, 2024

Study Completion Date

August 15, 2024

Conditions
Postdural Puncture Headache
Interventions
DRUG

Pregabalin 75mg

Group A (pregabalin group) received oral pregabalin treatment administered at 150 mg daily, with 75 mg given every 12 hours.

BIOLOGICAL

An epidural blood patch (EBP)

Group B (EBP group) received active therapy in the form of an EBP

COMBINATION_PRODUCT

conservative treatment.

Group C (control group) received conservative treatment providing recommendations to the patients, including 24 hours of bed rest, stool softener, and consuming a minimum of 2.0 liters of fluid daily. Analgesics were permitted for pain relief depending on the patient's disease status.

Trial Locations (1)

11865

Neveen Kohaf, Tanta

All Listed Sponsors
collaborator

Benha University

OTHER

lead

Al-Azhar University

OTHER

NCT06271486 - Pregabalin in Treatment of Postdural Puncture Headache | Biotech Hunter | Biotech Hunter